In parallel, BAG5 also modulates mitochondrial fission-fusion balance, as evidenced by increased MFN2 and decreased DRP1 expression upon BAG5 silencing, leading to enhanced mitochondrial fusion and reduced tumor aggressiveness. The gene discussed is MFN2; the disease is neoplasm.